CIK 0001439725
- Non-accelerated filer
- Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203986492
- Phone
- +1 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Exercise or conversion Director acquired 31,619 shares (option exercise)
- 4 Open-market buy Director bought 10,000 shares at $1.70 ($17,000)
- 4 Open-market buy Director bought 20,000 shares at $1.65 ($32,952)
- 4 Open-market buy Director bought 189,675 shares at $1.65 ($312,945)
- 4 Open-market buy Director bought 67,402 shares at $1.58 ($106,529)
- 4 Open-market buy Director bought 100,000 shares at $1.48 ($148,380)
- 4 Open-market buy Director bought 130,434 shares at $1.15 ($149,999)
- 4 Open-market buy Director bought 43,478 shares at $1.15 ($50,000)
- 4 Open-market buy Director bought 1,739,130 shares at $1.15 ($2,000,000)
- 4 Open-market buy Director bought 8,695,652 shares at $1.15 ($10,000,000)
- 4 Grant or award Chief Accounting Officer acquired 8,695 shares (grant or award)
- 4 Grant or award President & CEO acquired 65,217 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 4,347 shares (grant or award)
- 4 Open-market buy Director bought 2,669,562 shares at $1.15 ($3,069,996)
- 4 Open-market buy Director bought 173,913 shares at $1.15 ($200,000)
- 4 Grant or award Chief Scientific Officer acquired 12,000 shares (grant or award)
- 4 Grant or award CFO, Sec'y & Treasurer acquired 17,391 shares (grant or award)
- 4 Open-market sale Chief Commercial Officer sold 1,705 shares at an average $1.03 ($1,758)
- 4 Open-market sale Chief Scientific Officer sold 1,776 shares at an average $1.03 ($1,831)
- 4 Open-market sale President & CEO sold 13,777 shares at an average $1.03 ($14,205)
Page 12 of 17 · 336 filings